UBC BLUE BELL, Pa. and CARY, N.C., April 27, 2021 /PRNewswire/ — UBC, a late-stage research and patient-support services organization, and THREAD, a technology and service provide renabling DCTs, today announced UBC’s selection of THREAD to leverage decentralized approaches across...
  • March 15, 2022
  • 0 Comment
Read More
UBC The current public health crisis has accelerated collecting data in a decentralized manner. The biopharmacuetical industry had already begun to harness transformative approaches to collecting data in novel ways, including from remote sources across a wide range of settings...
  • March 15, 2022
  • 0 Comment
Read More
UBC SAN DIEGO and BLUE BELL, Pa., Feb. 3, 2022 /PRNewswire/ — UBC, a late-stage research and patient support services organization has partnered with Seqster PDM, Inc. (“Seqster”), the leading patient-centric healthcare technology company, to provide nationwide health record interoperability...
  • March 14, 2022
  • 0 Comment
Read More
H1 With the H1: Trial Landscape, our clients can leverage unique clinical insights for data driven decision-making, easily segmenting and analysing patient populations, to facilitate more diversity and inclusion in clinical trials.
  • March 4, 2022
  • 0 Comment
Read More
H1 Gone are the days when Conferences & Pubs defined the KOL landscape. Social media has transformed thought leadership, and if you’re not engaging Digital Opinion Leaders, then your teams will be a step behind some of the most meaningful...
  • March 4, 2022
  • 0 Comment
Read More
H1 Our client, a top 25 Global Pharma company, needed to better understand the top global key opinion leaders in pulmonary disease and oncology. They also needed to identify related second and third level rising stars to ensure continued adoption...
  • March 4, 2022
  • 0 Comment
Read More
H1 Our client was planning a launch of a product within a new indication. To ensure they were targeting the right audience, they wanted to better understand the treatment landscape across a total of five indications. H1 delivered the top...
  • March 4, 2022
  • 0 Comment
Read More
H1 has worked with the top Pharmaceuticals and Life Sciences Companies to help them better understand the HCP Universe. Specifically, H1 clients were seeking to increase MSL engagement. In reviewing the work done across those organizations, H1 uncovered an interesting...
  • March 4, 2022
  • 0 Comment
Read More
LABCORP Mobile Clinical Services (MCS) uses a patient-centric approach to transforming clinical trials, allowing for a suite of clinical trial visit services to be conducted at any time, wherever the patient may be by using a centrally managed network of...
  • March 3, 2022
  • 0 Comment
Read More
LABCORP Traditionally, clinical trials follow a standardized format, whereby the participant in the trial must attend the clinical site or sites for the purposes of screening, enrollment, treatment administration and data collection. However, the rigid structure of a conventional clinical...
  • March 3, 2022
  • 0 Comment
Read More